Siemens: Ask the Ultimate Power in Imaging MarketWatch - Nov 30, 2008 Siemens introduces the SOMATOM(R) Definition Flash, a new dual-source CT that requires only a fraction of the radiation dose that systems previously ...
Mammogram most effective 12 months after radiation treatment HealthTech Wire, Germany - FAIRFAX, VA, USA - (HealthTech Wire / News) - Breast cancer patients who receive breast-conserving therapy and radiation do not need a follow-up mammogram ...
Bus for breast cancer screening ready to roll West Virginia Public Broadcasting, WV - West Virginia has the 5 th highest death rate from breast cancer in the nation. West Virginia University?s Cancer Center hopes to fight that statistic with ...
Cancer fight leads woman to offer others hope Press of Atlantic City, NJ - Wood, who was diagnosed with an aggressive form of breast cancer that had spread to 22 lymph nodes, never paused to ask, "Why me? ...
Source: Google News
Recent News and Articles on the Keywords: breast cancer + cancer + breast Related to the article below (Last Update: 8/5/2008)
Sex After Breast Cancer U.S. News & World Report, DC - 37 minutes ago Yesterday I discussed Christina Applegate's diagnosis of breast cancer, and hundreds of reports on that news have been teeming with information?from the way ...
Christina Applegate's Breast Cancer: FAQ WebMD - 4, 2008 -- Actress Christina Applegate, 36, is being treated for early-stage breast cancer and is expected to recover fully. Her publicist announced the ...
Orange County Set to Race for the Cure(R) MarketWatch - "We are particularly appreciative this year for every Race participant, volunteer and sponsor who is dedicated to helping us end breast cancer forever -- I ...
Christina Applegate fighting breast cancer RTE.ie, Ireland - Emmy award-winning actress Christina Applegate is undergoing treatment for breast cancer, her publicist has revealed. Applegate, who is best known for her ...
Ariad Starts Phase II Study for Breast Cancer FDA news (subscription), VA - 54 minutes ago ... has initiated a Phase II clinical trial to examine oral deforolimus, its investigational mTOR inhibitor, in patients with advanced breast cancer. ...ARIA
An evaluation of genetic heterogeneity in 145 breast-ovarian cancer families - SA Narod, D Ford, P Devilee, RB Barkardottir, HT … - Am J Hum Genet, 1995 - pubmedcentral.nih.gov ... These families contain either a total of three or more cases of early-onset
(before age 60 years) breastcancer or ovarian cancer. ...
Lymphatic mapping and sentinel lymphadenectomy for breast cancer. - AE Giuliano, DM Kirgan, JM Guenther, DL Morton - Annals of Surgery, 1994 - pubmedcentral.nih.gov ... Copyright notice. Lymphatic mapping and sentinel lymphadenectomy for breastcancer. ...
Controversies in primary breastcancer management. Am J Surg. ...
Gene expression profiling predicts clinical outcome of breast cancer - LJ van't Veer, H Dai, MJ van de Vijver, YD He, AAM … - Nature, 2002 - Mass Med Soc ... Gene "Fingerprint" Improves Prognostic Accuracy in BreastCancer. ... van 't Veer LJ
et al. Gene expression profiling predicts clinical outcome of breastcancer. ...
The effect of raloxifene on risk of breast cancer in postmenopausal women - SR Cummings, S Eckert, KA Krueger, D Grady, TJ … - feedback, 2005 - biomedcentral.com ... Paper Report. The effect of raloxifene on risk of breastcancer in postmenopausal
women SR Cummings, S Eckert, KA Krueger, D Grady, TJ Powles, JA Cauley, L ...
Genetic analysis of breast cancer in the cancer and steroid hormone study. - EB Claus, N Risch, WD Thompson - American Journal of Human Genetics, 1991 - pubmedcentral.nih.gov ... Copyright notice. Genetic analysis of breastcancer in the cancer and steroid hormone
study. ... Age at onset as an indicator of familial risk of breastcancer. ...
Source: Google Scholar
Radiotherapy 'effective against early breast cancer'
Radiotherapy can effectively stop very early breast cancer returning years after surgery, new research suggests.
The researchers found that the most effective approach was radiotherapy of the whole breast followed by a boost.
Doctors analysed the records of 373 women aged 45 or younger from 18 centres around the world who had ductal carcinoma in situ, or DCIS, a condition that can lead to breast cancer.
All had received breast-conserving surgery. About a sixth of the patients were not given any radiotherapy after surgery. Almost half received one course of radiotherapy, and two fifths had radiotherapy with an extra boost.
Relapse-free survival at 10 years was 46 per cent for patients given no radiotherapy, 72 per cent for those given normal radiotherapy, and 86 per cent for women who received boosted radiotherapy.
Study leader Dr Guenther Gruber said: "Not using radiotherapy in young patients with DCIS resulted in an unacceptable number of women having their cancer return; these patients benefited from an additional dose boost."
In boosted radiotherapy, an additional shot of radiation is given on top of the normal treatment after surgery. The strategy is already known to work in cases of invasive breast cancer, especially in younger women.
Dr Gruber stressed that doctors must be aware of the hazards of applying high doses of radiotherapy.
"Radiotherapy has to be applied careful, especially in regard to heart, lungs and the other breast," he said.
No randomised trials have yet been undertaken to assess the effectiveness of boosted radiotherapy in women with such early stage breast cancer.
